DSI Assignments, LLC was the assignee for the benefit of creditors of this medical device start-up. Cohera patented TissuGlu®, a product to help healing from surgical procedures. When Cohera’s second product line failed to get FDA approval, the equity sponsor, which was also the secured creditor, elected to shut off funding and the company. While the company […]
30 April, 2024
Assignee for the Benefit of Creditors LifeHealth, LLC was a manufacturer of point-of-care (“POC”) diagnostic products that provided critical information to aid in the diagnosis, treatment and monitoring of illness and diseases. The company manufactured the IRMA TRUPOINT® Blood Analysis System. The company sought additional funding and sales opportunities, when those failed to materialize the […]
30 April, 2024
DSI presently serves are the Assignee for the Benefit of Creditors of CareSync, Inc. CareSync was a Delaware-based corporation in Tampa, Florida, that was a technology-enabled company that coordinated care for people with chronic diseases with over 130K registered users, 300+ employees, and over 200 accounts made up of 10,000 providers in 47 states. In […]
30 April, 2024